OXIS International Joins Forces With 'America's Dermatologist,' Dr. Tony Nakhla and Leading PR Firm to Support Entry Into Skin Care Market With EGT(TM)
Oxis International Inc.
24.04.2012 08:30
---------------------------------------------------------------------------
BEVERLY HILLS, Calif., 2012-04-24 08:30 CEST (GLOBE NEWSWIRE) --
OXIS International, Inc., the leader in oxidative stress since 1966
(OTCBB:OXIS) (Paris:OXI), today announced that it has entered into an Agreement
with Dr. Tony Nakhla, 'America's Dermatologist(tm),' to support the development of
and serve as spokesperson for its new EGT (L-ergothioneine) skin care product
line scheduled for market introduction in Summer, 2012.
Known in the media as 'America's Dermatologist(tm)', Dr. Tony Nakhla is a regular
healthcare news contributor having been featured in numerous outlets including
ELLE, New Beauty, ICON, SELF, Better Nutrition, Forbes, Better Homes and
Gardens, CNN, PBS, MSNBC, Daytime, E!, and many others discussing topics like
skin cancer prevention, nutrition and wellness, and the latest skin care and
anti-aging procedures. Dr. Nakhla is a board-certified dermatologist,
skin-cancer surgeon, cosmetic surgeon, and holistic-nutritional expert. He is
medical director and founder of OC Skin Institute - Dermatology Centers of
Orange County, in Southern California and author of the best-selling book, 'The
Skin Commandments: 10 Rules to Healthy, Beautiful Skin.'
Concurrent with the Nakhla Agreement, OXIS has also engaged LCO-Levine
Communications Office Inc., one of the country's leading public relations firms
to fully develop all media opportunities for the OXIS/Nakhla endeavors. LCO is
a multi-award winning agency having won the prestigious Bulldog Awards for
Excellence in Media Relations and Publicity, including:
2011 Winner: 'Best Crisis Communications Campaign of the Year'
2010 & 2006 Winner: 'Arts & Entertainment Campaign of the Year'
The new EGT(tm) based skin care line will focus not only on an aging population of
baby boomers seeking to retain and/or regain their youthful skin, but also a
younger audience seeking to maintain and enhance their beauty.
'Dr. Nakhla and LCO are the ideal partners for the execution of a
direct-to-consumer marketing strategy of this exciting new line of products,'
said David Saloff, Chairman and CEO of OXIS International.
'We are confident that with this team and these extraordinary products to go
along with our previously announced marketing partnership with EngageBDR, the
future is extremely bright for the EGT(tm) brand and for OXIS International,' he
added.
Dr. Nakhla adds, 'The oxidative stress mechanism is well known to be the main
contributing factor to skin aging via the sun's ultraviolet light and other
metabolic processes. I am thrilled to be collaborating with the world's leader
in oxidative stress including their team of world renowned scientists to put
forth the most cutting-edge, highest quality skin-care products available.'
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research,
diagnose, treat and prevent diseases of oxidative stress/inflammation
associated with damage from free radical and reactive oxygen species (ROS). The
company holds the rights to several therapeutic classes of compounds in the
area of oxidative stress, and has focused commercialization programs that
include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione
peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be
sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be
sold to the cosmetics markets as well as the functional food and beverage
markets. For more information, please visit www.oxis.com
About Dr. Tony Nakhla:
Dr. Tony N. Nakhla, D.O., F.A.O.C.D. is a board-certified dermatologist,
skin-cancer surgeon, cosmetic surgeon, and osteopathic physician with extensive
training in traditional and holistic medicine as well as nutrition. Dr. Nakhla
is medical director and founder of OC Skin Institute, in Orange County, CA, a
national center of excellence in skin health and beauty. For more information,
please visit www.TonyNakhla.com.
David Saloff
424-248 2311
David@Oxis.com
www.oxis.com
News Source: NASDAQ OMX
24.04.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Oxis International Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US6918294025
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Oxis International Inc.
24.04.2012 08:30
---------------------------------------------------------------------------
BEVERLY HILLS, Calif., 2012-04-24 08:30 CEST (GLOBE NEWSWIRE) --
OXIS International, Inc., the leader in oxidative stress since 1966
(OTCBB:OXIS) (Paris:OXI), today announced that it has entered into an Agreement
with Dr. Tony Nakhla, 'America's Dermatologist(tm),' to support the development of
and serve as spokesperson for its new EGT (L-ergothioneine) skin care product
line scheduled for market introduction in Summer, 2012.
Known in the media as 'America's Dermatologist(tm)', Dr. Tony Nakhla is a regular
healthcare news contributor having been featured in numerous outlets including
ELLE, New Beauty, ICON, SELF, Better Nutrition, Forbes, Better Homes and
Gardens, CNN, PBS, MSNBC, Daytime, E!, and many others discussing topics like
skin cancer prevention, nutrition and wellness, and the latest skin care and
anti-aging procedures. Dr. Nakhla is a board-certified dermatologist,
skin-cancer surgeon, cosmetic surgeon, and holistic-nutritional expert. He is
medical director and founder of OC Skin Institute - Dermatology Centers of
Orange County, in Southern California and author of the best-selling book, 'The
Skin Commandments: 10 Rules to Healthy, Beautiful Skin.'
Concurrent with the Nakhla Agreement, OXIS has also engaged LCO-Levine
Communications Office Inc., one of the country's leading public relations firms
to fully develop all media opportunities for the OXIS/Nakhla endeavors. LCO is
a multi-award winning agency having won the prestigious Bulldog Awards for
Excellence in Media Relations and Publicity, including:
2011 Winner: 'Best Crisis Communications Campaign of the Year'
2010 & 2006 Winner: 'Arts & Entertainment Campaign of the Year'
The new EGT(tm) based skin care line will focus not only on an aging population of
baby boomers seeking to retain and/or regain their youthful skin, but also a
younger audience seeking to maintain and enhance their beauty.
'Dr. Nakhla and LCO are the ideal partners for the execution of a
direct-to-consumer marketing strategy of this exciting new line of products,'
said David Saloff, Chairman and CEO of OXIS International.
'We are confident that with this team and these extraordinary products to go
along with our previously announced marketing partnership with EngageBDR, the
future is extremely bright for the EGT(tm) brand and for OXIS International,' he
added.
Dr. Nakhla adds, 'The oxidative stress mechanism is well known to be the main
contributing factor to skin aging via the sun's ultraviolet light and other
metabolic processes. I am thrilled to be collaborating with the world's leader
in oxidative stress including their team of world renowned scientists to put
forth the most cutting-edge, highest quality skin-care products available.'
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research,
diagnose, treat and prevent diseases of oxidative stress/inflammation
associated with damage from free radical and reactive oxygen species (ROS). The
company holds the rights to several therapeutic classes of compounds in the
area of oxidative stress, and has focused commercialization programs that
include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione
peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be
sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be
sold to the cosmetics markets as well as the functional food and beverage
markets. For more information, please visit www.oxis.com
About Dr. Tony Nakhla:
Dr. Tony N. Nakhla, D.O., F.A.O.C.D. is a board-certified dermatologist,
skin-cancer surgeon, cosmetic surgeon, and osteopathic physician with extensive
training in traditional and holistic medicine as well as nutrition. Dr. Nakhla
is medical director and founder of OC Skin Institute, in Orange County, CA, a
national center of excellence in skin health and beauty. For more information,
please visit www.TonyNakhla.com.
David Saloff
424-248 2311
David@Oxis.com
www.oxis.com
News Source: NASDAQ OMX
24.04.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Oxis International Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US6918294025
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------